Nitric Oxide Signaling (NOS)

O-Acetylschisantherin L is a natural lignan that serves as an inhibitor of nitric oxide (NO) production. It effectively suppresses LPS-induced NO production in BV-2 cells, demonstrating an IC50 value of 23.1 μM. This compound is useful in research focused on neuroinflammation and associated signaling pathways.

NOS-IN-3 is a selective inhibitor of nitric oxide synthase (NOS) with a notable affinity for inducible nitric oxide synthase (iNOS), exhibiting an IC50 of 4.6 μM, while sparing endothelial nitric oxide synthase (eNOS). This compound demonstrates minimal toxicity, making it suitable for investigations into diseases associated with the inducible isoform, such as septic shock. NOS-IN-3 is a valuable tool for elucidating the role of iNOS in various pathological conditions.

Valeriandoid F is an iridoid compound that acts as a potent inhibitor of nitric oxide (NO) production, exhibiting an IC50 value of 0.88 μM. This reagent possesses anti-inflammatory and antiproliferative properties, making it beneficial for studies related to inflammation and cancer research. Its ability to modulate NO levels may also provide insights into various pathological conditions associated with dysregulated nitric oxide signaling.

Britannilactone diacetate is a notable nitric oxide (NO) inhibitor, demonstrating significant efficacy in reducing NO production induced by lipopolysaccharide (LPS) in BV-2 microglial cells, with an effective concentration (EC50) of 6.3 μM. This compound is characterized by its favorable penetration across the blood-brain barrier, along with promising absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles, making it a valuable tool for investigating NO-related neuroinflammatory processes. Its unique mechanisms and properties position it for various research applications in neurobiology and pharmacology.

BYK 191023 is a selective inhibitor of inducible nitric-oxide synthase (iNOS) that functions as an L-arginine competitive antagonist, exhibiting an IC50 value of 86 nM for iNOS, while displaying significantly higher IC50 values of 17 µM and 162 µM for neuronal (nNOS) and endothelial (eNOS) nitric-oxide synthases, respectively. This compound is vital for studying the role of iNOS in various pathological conditions and demonstrates potential applications in inflammation research and related disease models.

9-Hydroxy-α-lapachone is a natural phenolic compound that serves as an effective nitric oxide (NO) production inhibitor. It demonstrates significant inhibitory activity, with an IC50 value of 4.64 µM, against LPS-induced NO production in RAW 264.7 macrophage cells. This compound is utilized in research applications focused on understanding inflammatory responses and nitric oxide signaling pathways.

1,3-PBIT dihydrobromide is a selective inhibitor of inducible nitric oxide synthase (iNOS), demonstrating a Ki value of 47 nM. In contrast, it shows reduced inhibition for endothelial (eNOS) and neuronal nitric oxide synthase (nNOS), with Ki values of 9 µM and 0.25 µM, respectively, for purified human enzymes. While it effectively inhibits iNOS in vitro, its cellular activity may be limited by membrane permeability, making it primarily useful for biochemical studies on nitric oxide pathways and their related regulatory mechanisms.

Sinomenine N-oxide is a potent inhibitor of nitric oxide (NO) production, exhibiting an IC50 value of 23.04 μM. This compound demonstrates significant anti-angiogenic, anti-inflammatory, and anti-rheumatic properties, making it valuable for research in cardiovascular and inflammatory diseases. Its mechanisms may offer insights into therapeutic approaches for conditions characterized by excess NO production.

Diplacol is a geranylated flavanone that functions as a nitric oxide (NO) inhibitor. Isolated from Paulownia coreana UYEKI, Diplacol exhibits notable anti-inflammatory activity. It effectively reduces NO production in LPS-stimulated Raw264.7 macrophage cells, with an IC50 value of 4.53 μM, making it a valuable reagent for studies focusing on inflammation and related signaling pathways.

L-NAPNA is a selective nitric oxide synthase (NOS) inhibitor, demonstrated to have an IC50 of 1.4 μM. It exhibits significant analgesic effects, as evidenced by its ability to reduce formalin-induced paw licking behavior in mice (ED50 of 57.2 mg/kg) and diminish acetic acid-induced abdominal writhing (ED50 of 25 mg/kg). This compound is valuable for exploring therapeutic approaches in research focused on central nervous system disorders.

Corydaldine is an alkaloid that acts as an inhibitor of nitric oxide synthase (NOS). It has been shown to effectively reduce nitric oxide production in BV2 microglial cells upon stimulation with lipopolysaccharide (LPS). This compound is relevant for research focusing on neuroinflammation and the roles of nitric oxide in various neurodegenerative diseases.

AR-C102222 is a spirocyclic fluoropiperidine quinazoline that selectively inhibits inducible nitric oxide synthase (iNOS). This compound demonstrates significant potential in mitigating neuropathic pain by reducing excessive nitric oxide production. Its specificity for iNOS makes it a valuable tool for researchers investigating the role of nitric oxide in pain pathology and related therapeutic interventions.

FR260330 is a selective, orally active inhibitor of inducible nitric oxide synthase (iNOS), functioning by suppressing iNOS dimerization. This compound significantly reduces nitric oxide accumulation in rat splenocytes and human DLD-110 cells, with IC50 values of 27 nM and 10 nM, respectively. FR260330 has demonstrated efficacy in ameliorating lipopolysaccharide-induced inflammatory responses in rat models, making it a valuable tool for researchers investigating inflammatory diseases and related pathways.

Anhydronotoptol is a potent inhibitor of nitric oxide (NO) production. It effectively inhibits NO generation in RAW 264.7 cells induced by lipopolysaccharide (LPS), with an IC50 value of 36.6 μM. This compound is valuable for research applications focused on inflammation and related signaling pathways.

1-Heptadecanoyl-rac-glycerol is an iNOS inhibitor that exhibits anti-inflammatory activity. By suppressing the expression of inducible nitric oxide synthase (iNOS), it effectively reduces inflammation. This compound is suitable for research applications focused on inflammatory diseases and related pathologies.

S-MTC acetate (S-Methyl-L-thiocitrulline acetate) is a potent inhibitor of inducible nitric oxide synthase (iNOS), selectively inhibiting iNOS while preserving the activity of constitutive nitric oxide synthase (nNOS). This compound is valuable for studying the roles of nitric oxide in various physiological and pathological processes, particularly in inflammation and neuroprotection research. Its specificity makes it an important tool for investigating the differential effects of nitric oxide in cellular signaling pathways.

Schisanchinin D is an NO release inhibitor derived from the fruits of Schisandra chinensis. It effectively inhibits the release of nitric oxide (NO) in lipopolysaccharide (LPS)-activated primary murine BV2 microglia cells. This compound holds potential for research in neurodegenerative diseases, particularly Alzheimer's disease (AD), due to its impact on microglial activation and neuroinflammatory processes.

Rubranol is a selective inhibitor of nitric oxide (NO) synthase, significantly reducing NO production in response to lipopolysaccharide (LPS) stimulation in activated macrophages, achieving a notable 74% inhibition. This compound is useful for researchers studying inflammatory responses and the role of NO in various pathological conditions. Its specific action on NO synthase makes it a valuable tool for investigating the modulation of nitric oxide pathways in cellular processes.

3β,15α-Dihydroxy-7,11,23-trioxo-lanost-8-dien-26-oic acid is a triterpene compound with a primary mechanism as a nitric oxide (NO) production inhibitor. It effectively suppresses NO production in BV-2 microglial cells stimulated by lipopolysaccharide (LPS), demonstrating an IC50 value of 6.50 μM. This compound serves as a valuable tool for anti-inflammatory research, potentially contributing to the development of therapeutic strategies targeting inflammatory pathways.

N-Benzylacetamidine hydrobromide is a selective inhibitor of inducible nitric oxide synthase (iNOS), exhibiting an IC50 of 0.20 μM. This compound is valuable for research focused on the modulation of nitric oxide production in inflammatory processes. Its selective action makes it a suitable tool for studying iNOS-related pathophysiology and potential therapeutic applications in related diseases.

(2R)-6-Methoxynaringenin is a selective inhibitor of nitric oxide (NO) synthesis. This flavonoid exhibits significant biological activity, with an IC50 value of 25.8 μM for NO production inhibition. Its ability to modulate NO levels makes it a valuable tool for research applications focused on vascular biology, inflammation, and associated signaling pathways.

Cindunistat is a selective inhibitor of inducible nitric oxide synthase (iNOS), demonstrating potent oral bioactivity. This compound is valuable for investigating the role of iNOS in various inflammatory and pathological conditions. Research applications include studies on cytokine modulation, neuroinflammation, and cardiovascular diseases, making it a crucial tool for exploring therapeutic interventions in nitric oxide-mediated pathways.

Demethylregelin is a triterpene that functions as an inhibitor of inducible nitric oxide synthase (iNOS). It effectively decreases iNOS protein expression and subsequent nitric oxide production in RAW264.7 macrophages upon lipopolysaccharide stimulation. This compound exhibits notable anti-inflammatory properties and is useful in research focusing on inflammatory signaling pathways and modulation of nitric oxide levels in cellular models.

NG-Amino-L-arginine hydrochloride is a potent inhibitor of nitric oxide synthase (NOS), specifically targeting the nNOS, iNOS, and eNOS isoforms. It effectively induces inactivation of these enzymes, with Ki values of 0.3 μM, 3 μM, and 2.5 μM, respectively. This reagent is valuable for research applications focused on the modulation of nitric oxide pathways and their roles in various physiological and pathological processes.

N-cis-Feruloyl tyramine is a natural phenolic compound that acts as an inhibitor of nitric oxide (NO) production. It demonstrates moderate inhibitory effects on lipopolysaccharide (LPS)-activated NO production in RAW 264.7 macrophage cells. This compound can be utilized in research to explore inflammatory responses and the modulation of NO signaling pathways.

Anti-inflammatory agent 1 is a nitric oxide synthase inhibitor that modulates inflammatory processes by reducing nitric oxide production. This compound exhibits significant anti-inflammatory activity, making it a valuable tool for research focused on conditions characterized by excessive inflammation. Its applications extend to studying various inflammatory pathways and assessing the therapeutic potential of nitric oxide modulation in diverse biological contexts.

Longiferone B is a daucane sesquiterpene derived from the rhizomes of Boesenbergia longiflora, acting as an inhibitor of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). It exhibits significant anti-inflammatory properties, effectively reducing nitric oxide production with an IC50 value of 21.0 μM. Longiferone B also suppresses the mRNA expression of iNOS and COX-2, making it a valuable compound for research in inflammation-related studies.

DL-1′-Acetoxychavicol acetate is a potent inhibitor of nitric oxide synthase (NOS). This compound demonstrates significant anti-inflammatory and anticancer properties by suppressing the activity of NADPH oxidase (NOX), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) in inflammatory cells. It has been shown to exhibit preventive effects in various inflammation-related cancer models, making it a valuable tool for research into inflammatory diseases and cancer therapy.

α-Chaconine is an inhibitor of COX-2 and iNOS, which demonstrates significant anti-inflammatory activity. It effectively reduces the transcriptional expression of COX-2, IL-1β, IL-6, and TNF-α. Additionally, α-Chaconine suppresses LPS-induced expression of iNOS and COX-2 at both the protein and mRNA levels, along with their promoter activities in RAW 264.7 macrophages. This makes α-Chaconine a valuable reagent for studies focused on inflammation and related signaling pathways.

Glycylglycine hydrochloride hydrate is an iNOS inhibitor that acts as a non-selective dipeptidase substrate. This compound is capable of passive diffusion across cell membranes, where it is hydrolyzed to glycine, playing a role in energy metabolism and antioxidant activities. Glycylglycine hydrochloride hydrate promotes the proliferation of spermatogonial stem cells and mitigates astrocyte overactivation while decreasing nitric oxide release. Additionally, it upregulates the expression of neurotrophic factors, aiding in nerve myelin repair. This reagent is suitable for research into male reproductive biology and the neuroprotective mechanisms in neurodegenerative diseases.

2-Thiouracil is a selective inhibitor of neuronal nitric oxide synthase (nNOS), exhibiting a Ki value of 20 μM. It effectively antagonizes BH4-induced nNOS dimerization, thereby modulating nitric oxide synthesis in neuronal tissues. In addition to its role as an nNOS inhibitor, 2-Thiouracil also has antithyroid properties and serves as a specific marker for melanoma detection. Furthermore, it promotes root growth in pea and corn, making it a valuable tool for various agricultural and biochemical research applications.

Glycylglycine, an iNOS inhibitor, is a dipeptide that serves as a non-selective glycylglycine dipeptidase substrate. It effectively crosses cell membranes through passive diffusion and is subsequently hydrolyzed to glycine, which participates in energy metabolism and antioxidant defense. This compound promotes the proliferation of spermatogonial stem cells (SSCs), mitigates astrocyte overactivation, and reduces nitric oxide (NO) release while enhancing the expression of neurotrophic factors such as PDGFA, FGF2, and CNTF, thereby supporting nerve myelin repair. Glycylglycine is valuable in research on male reproductive biology and neurodegenerative diseases, including the investigation of neuroprotective mechanisms in conditions like multiple sclerosis.